Clexio Biosciences
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Clexio Biosciences is a clinical-stage pharmaceutical company that develops novel drugs and drug-device combinations for the treatment of neurological and psychiatric conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clexio Biosciences Comparables
Compare Clexio Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evecxia Therapeutics | 82% | |
| MapLight Therapeutics | 76% | |
| Addex Therapeutics | 74% | |
Clexio Biosciences Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 49% MoM, reaching 3.6K.
- Jan 5, 2026
Monthly visitors increased 65% MoM.
Clexio Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Clexio Biosciences's valuation, stock price, and market status.